Interestingly, most of the relationships between drug resistance and the expression levels of the up-UDEGs ANLN, GPRC5A and SERPINB5 were positive (Figure 4B), indicating that these three genes are closely related to the resistance mechanisms of pancreatic cancer. The gene discussed is ANLN; the disease is pancreatic neoplasm.